Back to Supplement Score

Supplements for perimenopause

Evidence-based picks for sleep, mood, hot flashes, bone, and the wider symptom cluster of the transition years.

Perimenopause — the menopause transition typically spanning ages 40–55 — is dominated by erratic oestradiol fluctuations rather than the lower-but-stable pattern of post-menopause. The clinical picture is often a moving target: vasomotor symptoms, sleep disruption, mood change, cognitive complaints (the "brain fog" cluster), heavy or irregular periods, and accelerated bone-loss onset. Menopausal hormone therapy (MHT) is the most-evidenced symptom-relief intervention and is appropriate for a majority of symptomatic women in the under-60 window — the supplement aisle is for women who cannot or prefer not to use MHT, or as adjuncts to it. The picks below match the symptom-by-symptom evidence base.
82
Magnesium glycinate
Sleep · Mood · Migraine · Cramps
Tier 1
83
Vitamin D3
Bone · Muscle · Falls
Tier 1
80
Calcium (diet-first; supplement gap)
Bone · Vascular
Tier 1
79
Omega-3 (EPA/DHA)
Cardiovascular · Mood
Tier 1
73
Vitamin K2 (MK-7)
Bone · Vascular calcification
Tier 2
71
Ashwagandha (KSM-66)
Sleep · Stress · Anxiety
Tier 2
74
Saffron (Crocus sativus)
Mood · Hot flashes · Sleep
Tier 1
62
Black cohosh (Cimicifuga racemosa)
Hot flashes · Mood (mixed evidence)
Tier 3

The perimenopause stack — by symptom cluster

Vasomotor (hot flashes, night sweats)

MHT is the most effective intervention; non-hormonal trial-evidenced options include SSRIs/SNRIs (paroxetine, venlafaxine), gabapentin, and the newer NK3R antagonists (fezolinetant). Supplements with the cleanest signal: saffron 30 mg/day (Kashani 2018 trial showed reduction in vasomotor symptoms), and (with caveats) black cohosh — the 2012 Cochrane was inconclusive, but some standardised extracts have positive RCTs. Discuss black cohosh use with prescriber given rare hepatotoxicity reports.

Sleep and night-time symptoms

Sleep disruption in perimenopause has multiple drivers: vasomotor wake-ups, anxiety, restless legs. Magnesium glycinate 300–400 mg elemental in the evening is the core supplement. L-theanine 200 mg as needed for sleep-onset difficulty. Low-dose melatonin (0.3–0.5 mg) for sleep-phase shifts; not a primary insomnia treatment but useful adjunct. Saffron has signal for sleep-quality improvement in this cohort. If sleep is severely impaired by hot flashes, MHT or non-hormonal alternatives (fezolinetant) outperform supplements substantially.

Mood — anxiety, irritability, depressive symptoms

Saffron 30 mg/day has the cleanest single-supplement signal in perimenopausal mood symptoms — non-inferior to SSRIs in some trials, fewer side effects. Omega-3 (DHA-emphasised) at 2 g/day for depressive symptoms. Ashwagandha (KSM-66) 300–600 mg/day for anxiety component (avoid in thyroid disease). For clinical depression, this is a primary-care or psychiatry conversation — not a supplement-only approach.

Bone health — start prevention now, not later

Perimenopause is the inflection point for accelerated bone loss; bone density should be assessed if risk factors warrant (FRAX, DXA). Vitamin D3 1000–2000 IU/day to target 30–50 ng/mL. Calcium 1000–1200 mg/day total intake — diet-first, supplement only the gap, take with food. Vitamin K2 (MK-7) 100–180 mcg/day modulates calcium handling. Weight-bearing and resistance exercise outweighs all supplements for bone density.

Cardiovascular shift

Perimenopause is when LDL, blood pressure, and lipid trajectories often worsen. Omega-3 EPA/DHA 1–2 g/day for cardiovascular substrate. Mediterranean-pattern eating and exercise dominate; check BP and lipid panel at this transition.

Heavy or irregular periods

Iron status frequently drops with heavy menstrual bleeding — test ferritin and supplement if low. Don't supplement iron empirically. This is also a moment to evaluate uterine pathology (fibroids, polyps, hyperplasia) — heavy or prolonged bleeding warrants GYN evaluation.

Brain fog

Often improves with treatment of underlying sleep disruption, MHT (if appropriate), and mood. Supplement-aisle effects are modest. Omega-3 DHA, magnesium L-threonate if available, and addressing reversible deficiencies (B12, thyroid, vitamin D) are the high-utility moves. Don't chase "cognitive enhancer" products — the levers are sleep + hormones + cardiovascular health.

What to skip

Educational reference, not medical advice. Discuss any supplement change with a qualified clinician before acting on this list. Perimenopausal symptoms with significant quality-of-life impact warrant evaluation; MHT is the most-evidenced intervention for many women and the conversation belongs with primary care, gynecology, or menopause specialists.

Sources

  1. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767–794. PMID: 35797481
  2. Kashani L, et al. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial. Arch Gynecol Obstet. 2018;297(3):717–724. PMID: 29318406
  3. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev. 2012;(9):CD007244. PMID: 22972105
  4. Boyle NB, et al. The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients. 2017;9(5):429. PMID: 28445426
  5. Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. PMID: 31517876
  6. Avis NE, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531–539. PMID: 25686030
See also: Perimenopause condition stack · Menopause hot flashes · Supplements for menopause · Methodology